Equity Profile
Pre-Earnings Brief
LeMaitre Vascular Inc. (LMAT) operates in the health care sector, specifically focusing on medical devices for vascular surgery....
EPS
Earnings per share is a key indicator of profitability and will help investors gauge the company's financial health this quarter.
Revenue
Revenue figures will provide insight into the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
3Q
EPS Beat Rate
75%
Avg EPS Surprise
+5.38%
Avg Stock Reaction
-0.46%
In Q4-2025, LeMaitre reported an EPS of $0.68, slightly exceeding expectations. The stock reacted positively, gaining 0.69% the following day.
Management Promises & Guidance
Analysts expect LeMaitre to report a solid quarter with an EPS of $0.66 and revenue of $67 million. The company has a history of beating earnings estimates, which could influence market sentiment.
Bull Case
If LeMaitre exceeds the EPS estimate, it could signal strong demand for its products and potentially lead to increased stock prices, as seen in previous quarters.
Bear Case
Conversely, if the company fails to meet expectations, it may raise concerns about market demand and profitability, leading to a negative stock reaction.
EPS
0.66Earnings per share is a key indicator of profitability and will help investors gauge the company's financial health this quarter.
Revenue
67MRevenue figures will provide insight into the company's sales performance and market demand for its products.
Expectations
The print will turn on these two things.
Q1
Will EPS exceed $0.66?
A beat on EPS could reinforce confidence in the company's growth and profitability, impacting stock performance.
Q2
What are the revenue projections for the next quarter?
Guidance on future revenue will be crucial for investors to assess the company's growth trajectory and market position.
Edge
Why consensus could be wrong
The Street may be underestimating the potential for stronger-than-expected revenue growth driven by new product launches.
Supporting Evidence
LeMaitre has a history of beating EPS estimates, which could indicate stronger performance this quarter.
The options market is pricing in a higher move than historical averages, suggesting that traders expect significant volatility.
Recent trends in the health care sector show increasing demand for vascular products, which may not be fully reflected in consensus estimates.
Key Risk
If revenue exceeds $68 million, it could challenge the current consensus and shift market sentiment positively.
Edge
Pre-commit to what would confirm each case.
This quarter's performance is critical as it will reflect the company's ability to maintain growth amid market challenges.
Bull Confirmed If
An EPS of $0.68 or higher would confirm the bull case, indicating strong performance.
Bear Confirmed If
An EPS below $0.64 would support the bear case, raising concerns about demand.
Pre-Earnings Positioning
Implied Move
±5.57%
Historical Avg
±1.0%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±5.3% while LMAT has averaged ±1.0% over the last 8 prints — setup is pricing rich.
30d HV
26.7%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If LeMaitre beats expectations, history suggests a potential stock increase of around 1.00% as investor confidence grows.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline of approximately 1.80%, reflecting investor disappointment and concerns over future growth.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
LOEWS CORP